Search
Century Therapeutics Inc
IPSCAdd to Watchlist
1.690USD
-0.070-3.98%
Close 09-24 16:00（ET）
304.79MMarket Cap
LossP/E TTM
About Century Therapeutics Inc Company
Century Therapeutics, Inc. is a biotechnology company. The Company is focused on developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies and autoimmune diseases. The Company has created allogeneic cell therapy platform that includes induced pluripotent stem cells (iPSCs), differentiation know-how to generate immune effector cells from iPSCs, or iPSC- derived cells, clustered regularly interspaced short palindromic repeats, to incorporate multiple transgenes and remove target genes. The Company’s product candidates include CNTY-101, CNTY-308, CNTY-341, CNTY-107, and CNTY-104. Its lead product candidate CNTY-101 is a CAR-iNK cell therapy with six precision gene edits in a Phase I clinical trial for patients with B-cell mediated autoimmune diseases. CNTY-308 is a CD19-targeted, iPSC derived CAR T cell therapy. CNTY-341 is a dual-targeted CD19 and CD22 iPSC-derived CAR-T cell therapy.
Century Therapeutics Inc Profile
Ticker SymbolIPSC
Company nameCentury Therapeutics Inc
IPO dateJun 17, 2021
CEOPfeiffenberger (Brent)
Number of employees140
Security typeOrdinary Share
Fiscal year-endJun 17
Address25 N 38Th Street, 11Th Floor
CityPHILADELPHIA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code19104
Phone12159814000
Websitehttps://www.centurytx.com/
Ticker SymbolIPSC
IPO dateJun 17, 2021
CEOPfeiffenberger (Brent)
Company Executives of Century Therapeutics Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Brent Pfeiffenberger, Pharm.D.
Dr. Brent Pfeiffenberger, Pharm.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
643.98K
-2.22%
Dr. Brent Pfeiffenberger, Pharm.D.
Dr. Brent Pfeiffenberger, Pharm.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
643.98K
-2.22%
Dr. Brent Pfeiffenberger, Pharm.D.
Dr. Brent Pfeiffenberger, Pharm.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
643.98K
-2.22%
Mr. Douglas Carr, CPA
Mr. Douglas Carr, CPA
Principal Finance Officer, Senior Vice President - Finance and Operations, Secretary
Principal Finance Officer, Senior Vice President - Finance and Operations, Secretary
490.34K
-0.39%
Mr. Douglas Carr, CPA
Mr. Douglas Carr, CPA
Principal Finance Officer, Senior Vice President - Finance and Operations, Secretary
Principal Finance Officer, Senior Vice President - Finance and Operations, Secretary
490.34K
-0.39%
Mr. Douglas Carr, CPA
Mr. Douglas Carr, CPA
Principal Finance Officer, Senior Vice President - Finance and Operations, Secretary
Principal Finance Officer, Senior Vice President - Finance and Operations, Secretary
490.34K
-0.39%
Dr. Gregory (Greg) Russotti, Ph.D.
Dr. Gregory (Greg) Russotti, Ph.D.
Chief Technology and Manufacturing Officer
Chief Technology and Manufacturing Officer
364.97K
-0.86%
Dr. Gregory (Greg) Russotti, Ph.D.
Dr. Gregory (Greg) Russotti, Ph.D.
Chief Technology and Manufacturing Officer
Chief Technology and Manufacturing Officer
364.97K
-0.86%
Dr. Gregory (Greg) Russotti, Ph.D.
Dr. Gregory (Greg) Russotti, Ph.D.
Chief Technology and Manufacturing Officer
Chief Technology and Manufacturing Officer
364.97K
-0.86%
Dr. Chad Cowan, Ph.D.
Dr. Chad Cowan, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
227.37K
-0.16%
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Brent Pfeiffenberger, Pharm.D.
Dr. Brent Pfeiffenberger, Pharm.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
643.98K
-2.22%
Dr. Brent Pfeiffenberger, Pharm.D.
Dr. Brent Pfeiffenberger, Pharm.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
643.98K
-2.22%
Dr. Brent Pfeiffenberger, Pharm.D.
Dr. Brent Pfeiffenberger, Pharm.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
643.98K
-2.22%
Mr. Douglas Carr, CPA
Mr. Douglas Carr, CPA
Principal Finance Officer, Senior Vice President - Finance and Operations, Secretary
Principal Finance Officer, Senior Vice President - Finance and Operations, Secretary
490.34K
-0.39%
Mr. Douglas Carr, CPA
Mr. Douglas Carr, CPA
Principal Finance Officer, Senior Vice President - Finance and Operations, Secretary
Principal Finance Officer, Senior Vice President - Finance and Operations, Secretary
490.34K
-0.39%
Mr. Douglas Carr, CPA
Mr. Douglas Carr, CPA
Principal Finance Officer, Senior Vice President - Finance and Operations, Secretary
Principal Finance Officer, Senior Vice President - Finance and Operations, Secretary
490.34K
-0.39%
FAQs
Who are the top five shareholders of Century Therapeutics Inc?
The top five shareholders of Century Therapeutics Inc are: Dr. Brent Pfeiffenberger, Pharm.D.
How many institutions hold shares of Century Therapeutics Inc (IPSC)?
As of 2026Q1, 171 institutions hold shares of Century Therapeutics Inc, with a combined market value of approximately 114.13M, accounting for 63.28% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 68165106.00.